homovanillic acid

Homovanillic acid (Vanillacetic acid), a dopamine metabolite, is linked to aromatic L-amino acid decarboxylase deficiency, growth hormone deficiency, celiac disease, and sepiapterin reductase deficiency.

Homovanillic acid sulfate (sodium) is a phenolic compound found in olive oil and a metabolite of dopamine. It increases in the body during acute kidney injury and serves as a biomarker for the early detection of kidney diseases.

Homovanillic acid-D3 is a deuterated compound of Homovanillic acid (T3S0507).

Homovanillic acid sulfate is used as a reagent to detect oxidative enzymes, and is associated with dopamine levels in the brain.In psychiatry and neuroscience, brain and cerebrospinal fluid levels of homovanillic acid are measured as a marker of metabolic

Homovanillic acid-D5 is a deuterated Homovanillic acid, which can be used to study the metabolism of Homovanillic acid (T3S0507) in vivo. Homovanillic acid (T3S0507) is a dopamine metabolite, which is an indicator of central dopamine function in primates. Homovanillic acid (T3S0507) is a dopamine metabolite and an indicator of central dopamine function in primates.

Homovanillic Acid-13C-D3 the 13C and deuterated compound of Homovanillic Acid (T3S0507). Homovanillic Acid has a CAS number of 306-08-1. Homovanillic acid is a dopamine metabolite found to be associated with aromatic L-amino acid decarboxylase deficiency, celiac disease, growth hormone deficiency, and sepiapterin reductase deficiency.

Homovanillic acid (Standard) is a reference standard for research and analysis in studies involving Homovanillic acid. Homovanillic acid (Vanillacetic acid) is a dopamine metabolite found to be associated with aromatic L-amino acid decarboxylase deficiency, growth hormone deficiency, celiac disease, and sepiapterin reductase deficiency.

Homovanillic Acid-[13C,D3] (Standard) is a reference standard of Homovanillic Acid-[13C,D3] intended for quantitative analysis, quality control, and related biochemical research applications.

Homovanillic Acid-D5 (Standard) is a reference standard of Homovanillic Acid-D5 intended for quantitative analysis, quality control, and related biochemical research applications. Homovanillic acid-d5 (Vanilacetic acid-d5) is a deuterated Homovanillic acid, which can be used to study the metabolism of Homovanillic acid in vivo. Homovanillic acid is a dopamine metabolite, which is an indicator of central dopamine function in primates. Homovanillic acid is a dopamine metabolite and an indicator of central dopamine function in primates.

Isohomovanillic acid (Homoisovanillic acid is used as pharmaceutical intermediates.

CGP-28014 is an inhibitor of catechol-O-methyltransferase. CGP-28014 increases the renal excretion of both dopamine and dihydroxyphenylacetic acid (DOPAC) but does not affect renal sodium handling indicating a different mechanism of action. CGP-28014 sign

Zonisamide-13C2,15N is intended for use as an internal standard for the quantification of zonisamide by GC- or LC-MS. Zonisamide (T0267) is an antiepileptic agent.1 It selectively inhibits the repeated firing of sodium channels (IC50 = 2 μg/ml) in mouse embryo spinal cord neurons and inhibits spontaneous channel firing when used at concentrations greater than 10 μg/ml.2 In rat cerebral cortex neurons, zonisamide (1-1,000 μM) inhibits T-type calcium channels with a maximum reduction of 60% of the calcium current.3 Zonisamide (T0267) inhibits H. pylori recombinant carbonic anhydrase (CA) and the human CA isoforms I, II, and V with Ki values of 218, 56, 35, and 21 nM, respectively.4,5 In mice, it has anticonvulsant activity against maximal electroshock seizure (MES) and pentylenetetrazole-induced maximal, but not minimal, seizures (ED50s = 19.6, 9.3, and >500 mg/kg, respectively). Zonisamide (T0267) (40 mg/kg, p.o.) prevents MPTP-induced decreases in the levels of dopamine , but not homovanillic acid or dihydroxyphenyl acetic acid , and increases MPTP-induced decreases in the dopamine turnover rate in mouse striatum in a model of Parkinson's disease.6 Formulations containing zonisamide have been used in the treatment of partial seizures in adults with epilepsy.

N,N-Dipropyldopamine is a dopamine receptor agonist.1,2,3 It decreases dihydrophenylalanine (DOPA) levels in the limbic forebrain and striatum of reserpinized rats (ED50s = 25 and 20 μmol/kg, respectively), as well as reduces homovanillic acid levels in rat striatum when administered at a dose of 80 μmol/kg.1 N,N-Dipropyldopamine (0.5-16 mg/kg) reduces spontaneous locomotor activity in mice, an effect that can be reversed by the antipsychotic spiroperidol.2,3

(4-Hydroxy-3-methoxyphenyl) acetic-2,2-D2 Acid is a deuterated compound of  (4-Hydroxy-3-methoxyphenyl) acetic Acid (TMSM-3295). (4-Hydroxy-3-methoxyphenyl)acetic Acid has a CAS number of 306-08-1. Homovanillic acid is a dopamine metabolite found to be associated with aromatic L-amino acid decarboxylase deficiency, celiac disease, growth hormone deficiency, and sepiapterin reductase deficiency.

Nitisinone-13C6 (Standard) is a reference standard of Nitisinone-13C6 intended for quantitative analysis, quality control, and related biochemical research applications. Nitisinone-13C6 is used as an internal standard when quantitatively analyzing nitisinone by gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry. Nitisinone is an inhibitor of 4-hydroxyphenylpyruvate dioxygenase (HPPD), which converts 4-hydroxyphenylpyruvate (HPPA) to homovanillic acid during the tyrosine degradation pathway.

(4-Hydroxy-3-Methoxyphenyl)Acetic-2,2-D2 Acid (Standard) is a reference standard of (4-Hydroxy-3-Methoxyphenyl)Acetic-2,2-D2 Acid intended for quantitative analysis, quality control, and related biochemical research applications. (4-Hydroxy-3-methoxyphenyl)acetic-2,2-d2 Acid is a deuterated compound of (4-Hydroxy-3-methoxyphenyl)acetic Acid. (4-Hydroxy-3-methoxyphenyl)acetic Acid has a CAS number of 306-08-1. Homovanillic acid is a dopamine metabolite found to be associated with aromatic L-amino acid decarboxylase deficiency, celiac disease, growth hormone deficiency, and sepiapterin reductase deficiency.